{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:42:18Z","timestamp":1790739738393,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","annalspathology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.anndiagpath.2016.10.005","type":"journal-article","created":{"date-parts":[[2016,10,19]],"date-time":"2016-10-19T04:35:59Z","timestamp":1476851759000},"page":"16-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Hepatosplenic T-cell lymphoma arising in patients with immunodysregulatory disorders: a study of 7 patients who did not receive tumor necrosis factor\u2013\u03b1 inhibitor therapy and literature review"],"prefix":"10.1016","volume":"26","author":[{"given":"Mariko","family":"Yabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahya","family":"Daneshbod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Davanlou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos E.","family":"Bueso-Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa J.","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken H.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto N.","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2016.10.005_bb0005","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","first-page":"292","article-title":"Hepatosplenic T-cell lymphoma","author":"Gaulard","year":"2008"},{"issue":"5","key":"10.1016\/j.anndiagpath.2016.10.005_bb0010","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/PAS.0000000000000614","article-title":"Prognostic factors of hepatosplenic T-cell lymphoma (HSTCL): a clinicopathologic, immunophenotypic, and cytogenetic analysis of 28 patients","volume":"40","author":"Yabe","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1016\/j.anndiagpath.2016.10.005_bb0015","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/sj.leu.2400742","article-title":"Isochromosome 7q: the primary cytogenetic abnormality in hepatosplenic gammadelta T cell lymphoma","volume":"11","author":"Alonsozana","year":"1997","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.anndiagpath.2016.10.005_bb0020","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1038\/ajg.2011.283","article-title":"Role of thiopurine and anti-TNF therapy in lymphoma in inflammatory bowel disease","volume":"106","author":"Herrinton","year":"2011","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2016.10.005_bb0025","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/ajg.2012.334","article-title":"T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-alpha) inhibitors: results of the REFURBISH study","volume":"108","author":"Deepak","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"10.1016\/j.anndiagpath.2016.10.005_bb0030","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1136\/gut.2004.049460","article-title":"Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine","volume":"54","author":"Kandiel","year":"2005","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.anndiagpath.2016.10.005_bb0035","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1097\/PAS.0000000000000095","article-title":"Iatrogenic immunodeficiency-associated classical Hodgkin lymphoma: clinicopathologic features of 54 cases reported in the literature","volume":"37","author":"Miranda","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2016.10.005_bb0040","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1309\/AJCPJSA1E1YWSZEY","article-title":"Clinicopathologic, immunophenotypic, cytogenetic and molecular features of \u03b3\u03b4 T-cell large granular lymphocytic leukemia: an analysis of 14 patients suggests biologic differences with \u03b1\u03b2 T-cell large granular lymphocytic leukemia","volume":"144","author":"Yabe","year":"2015","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"10.1016\/j.anndiagpath.2016.10.005_bb0045","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1309\/JQMR-323G-71Y9-M7MB","article-title":"Cytogenetic findings in mantle cell lymphoma cases with a high level of peripheral blood involvement have a distinct pattern of abnormalities","volume":"116","author":"Onciu","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.anndiagpath.2016.10.005_bb0050","series-title":"ISCN 2013: an international system for human cytogenetic nomenclature","first-page":"2013","author":"Shaffer","year":"2013"},{"issue":"1","key":"10.1016\/j.anndiagpath.2016.10.005_bb0055","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1309\/5WFQ-N12E-DT05-UX1T","article-title":"A novel four-color PCR assay to assess T-cell receptor gamma gene rearrangements in lymphoproliferative lesions","volume":"116","author":"Vega","year":"2001","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2016.10.005_bb0060","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/MPG.0b013e31802f6424","article-title":"Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease","volume":"44","author":"Mackey","year":"2007","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"2","key":"10.1016\/j.anndiagpath.2016.10.005_bb0065","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00005176-200502000-00026","article-title":"Hepatosplenic T-cell lymphoma in an adolescent patient after immunomodulator and biologic therapy for Crohn disease","volume":"40","author":"Thayu","year":"2005","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"10.1016\/j.anndiagpath.2016.10.005_bb0070","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1080\/1042819021000035662","article-title":"Hepatosplenic T-gammadelta lymphoma in a patient with Crohn's disease treated with azathioprine","volume":"44","author":"Navarro","year":"2003","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"10.1016\/j.anndiagpath.2016.10.005_bb0075","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1600-0609.2006.00646.x","article-title":"A case of hepatosplenic gamma-delta T-cell lymphoma with a transient response to fludarabine and alemtuzumab","volume":"76","author":"Mittal","year":"2006","journal-title":"Eur J Haematol"},{"issue":"7","key":"10.1016\/j.anndiagpath.2016.10.005_bb0080","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1080\/10428190701345433","article-title":"Hepatosplenic T-cell lymphoma in a patient with Crohn's disease who received infliximab therapy","volume":"48","author":"Zeidan","year":"2007","journal-title":"Leuk Lymphoma"},{"issue":"7","key":"10.1016\/j.anndiagpath.2016.10.005_bb0085","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1080\/10428190802087488","article-title":"Long-term survival in two patients with hepatosplenic T cell lymphoma treated with interferon-alpha","volume":"49","author":"Humphreys","year":"2008","journal-title":"Leuk Lymphoma"},{"issue":"8","key":"10.1016\/j.anndiagpath.2016.10.005_bb0090","doi-asserted-by":"crossref","first-page":"464","DOI":"10.5694\/j.1326-5377.2008.tb02124.x","article-title":"Hepatosplenic T-cell lymphoma following infliximab therapy for Crohn's disease","volume":"189","author":"Drini","year":"2008","journal-title":"Med J Aust"},{"issue":"9","key":"10.1016\/j.anndiagpath.2016.10.005_bb0095","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/ibd.20802","article-title":"Crohn's disease, hepatosplenic T-cell lymphoma and no biological therapy: are we barking up the wrong tree?","volume":"15","author":"Moran","year":"2009","journal-title":"Inflamm Bowel Dis"},{"issue":"7","key":"10.1016\/j.anndiagpath.2016.10.005_bb0100","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/lt.21748","article-title":"Hepatosplenic gammadelta T-cell lymphoma after liver transplantation: report of the first 2 cases and review of the literature","volume":"15","author":"Roelandt","year":"2009","journal-title":"Liver Transpl"},{"issue":"7","key":"10.1016\/j.anndiagpath.2016.10.005_bb0105","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nrgastro.2009.87","article-title":"Hepatosplenic T-cell lymphoma in a patient with Crohn's disease","volume":"6","author":"Beigel","year":"2009","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2016.10.005_bb0110","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3816\/CLML.2010.n.021","article-title":"Hepatosplenic T-cell lymphoma in a young man with Crohn's disease: case report and literature review","volume":"10","author":"Ochenrider","year":"2010","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"4","key":"10.1016\/j.anndiagpath.2016.10.005_bb0115","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1309\/YTTC-F55W-K9CP-EPX5","article-title":"Hepatosplenic gamma-delta T-cell lymphoma as a late-onset posttransplant lymphoproliferative disorder in renal transplant recipients","volume":"113","author":"Wu","year":"2000","journal-title":"Am J Clin Pathol"},{"issue":"8","key":"10.1016\/j.anndiagpath.2016.10.005_bb0120","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1155\/2011\/148927","article-title":"Hepatosplenic lymphoma presenting initially as hemophagocytic syndrome in a 21-year-old man with Crohn's disease: a case report and literature review","volume":"25","author":"Cote-Daigneault","year":"2011","journal-title":"Can J Gastroenterol"},{"issue":"5","key":"10.1016\/j.anndiagpath.2016.10.005_bb0125","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s12185-012-1081-2","article-title":"Hepatosplenic alphabeta T-cell lymphoma associated with azathioprine therapy","volume":"95","author":"Rashidi","year":"2012","journal-title":"Int J Hematol"},{"issue":"8","key":"10.1016\/j.anndiagpath.2016.10.005_bb0130","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/MPH.0b013e3182707592","article-title":"Peripheral T-cell lymphoma in children and adolescents: a single-institution experience","volume":"34","author":"Al Mahmoud","year":"2012","journal-title":"J Pediatr Hematol Oncol"},{"issue":"6","key":"10.1016\/j.anndiagpath.2016.10.005_bb0135","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.3109\/10428194.2012.740563","article-title":"Hepatosplenic alphabeta T-cell lymphoma arising after long-term azathioprine therapy successfully treated with allogeneic bone marrow transplant","volume":"54","author":"Basic Kinda","year":"2013","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"10.1016\/j.anndiagpath.2016.10.005_bb0140","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.reuma.2013.12.005","article-title":"Hepatosplenic gammadelta T-cell lymphoma and Sjogren's syndrome","volume":"10","author":"Godinho","year":"2014","journal-title":"Reumatol Clin"},{"issue":"3","key":"10.1016\/j.anndiagpath.2016.10.005_bb0145","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/imj.12363","article-title":"Hepatosplenic T-cell lymphoma, immunosuppressive agents and biologicals: what are the risks?","volume":"44","author":"Subramaniam","year":"2014","journal-title":"Intern Med J"},{"issue":"7","key":"10.1016\/j.anndiagpath.2016.10.005_bb0150","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/00000478-199707000-00006","article-title":"Hepatosplenic gamma\/delta T-cell lymphoma: a report of two cases in immunocompromised patients, associated with isochromosome 7q","volume":"21","author":"Francois","year":"1997","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2016.10.005_bb0155","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1309\/TC9U-FAV7-0QBW-6DFC","article-title":"Hepatosplenic gamma\/delta T-cell lymphoma in immunocompromised patients. Report of two cases and review of literature","volume":"116","author":"Khan","year":"2001","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2016.10.005_bb0160","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.clml.2012.09.002","article-title":"Intensive induction chemotherapy followed by early high-dose therapy and hematopoietic stem cell transplantation results in improved outcome for patients with hepatosplenic T-cell lymphoma: a single institution experience","volume":"13","author":"Voss","year":"2013","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"6","key":"10.1016\/j.anndiagpath.2016.10.005_bb0165","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s00277-015-2299-x","article-title":"Hepatosplenic gammadelta T-cell lymphoma after allogeneic bone marrow transplantation","volume":"94","author":"Vekemans","year":"2015","journal-title":"Ann Hematol"},{"issue":"7","key":"10.1016\/j.anndiagpath.2016.10.005_bb0170","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1080\/10428190701400071","article-title":"Graft-versus-lymphoma effect in progressive hepatosplenic gamma\/delta T-cell lymphoma","volume":"48","author":"He","year":"2007","journal-title":"Leuk Lymphoma"},{"issue":"12","key":"10.1016\/j.anndiagpath.2016.10.005_bb0175","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1097\/MEG.0b013e32834bb90a","article-title":"Hepatosplenic T-cell lymphoma in patients receiving TNF-alpha inhibitor therapy: expanding the groups at risk","volume":"23","author":"Parakkal","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.anndiagpath.2016.10.005_bb0180","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/MIB.0000000000000243","article-title":"Cancer and immunomodulators in inflammatory bowel diseases","volume":"21","author":"Biancone","year":"2015","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"10.1016\/j.anndiagpath.2016.10.005_bb0185","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.crohns.2010.05.006","article-title":"Hepatosplenic T-cell lymphoma and inflammatory bowel disease","volume":"4","author":"Thai","year":"2010","journal-title":"J Crohns Colitis"},{"issue":"9","key":"10.1016\/j.anndiagpath.2016.10.005_bb0190","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.4049\/jimmunol.142.9.3045","article-title":"Tissue localization and CD8 accessory molecule expression of T gamma delta cells in humans","volume":"142","author":"Bucy","year":"1989","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.anndiagpath.2016.10.005_bb0195","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1084\/jem.171.5.1597","article-title":"Evidence for extrathymic changes in the T cell receptor gamma\/delta repertoire","volume":"171","author":"Parker","year":"1990","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.anndiagpath.2016.10.005_bb0200","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2036.2011.04905.x","article-title":"Review article: the benefits of pharmacogenetics for improving thiopurine therapy in inflammatory bowel disease","volume":"35","author":"Chouchana","year":"2012","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913416302763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913416302763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T10:20:20Z","timestamp":1692526820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913416302763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":40,"alternative-id":["S1092913416302763"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2016.10.005","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatosplenic T-cell lymphoma arising in patients with immunodysregulatory disorders: a study of 7 patients who did not receive tumor necrosis factor\u2013\u03b1 inhibitor therapy and literature review","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2016.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}